Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02415621
Recruitment Status : Active, not recruiting
First Posted : April 14, 2015
Last Update Posted : June 22, 2022
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 12, 2019
Estimated Study Completion Date : December 2022